Selected article for: "allocation concealment random sequence generation and bias risk"
Author: Desye Gebrie; Desalegn Getnet; Tsegahun Manyazewal
Title: Efficacy of remdesivir versus placebo for the treatment of COVID-19: A protocol for systematic review and meta-analysis of randomized controlled trials
  • Document date: 2020_4_14
    • ID: aosmo568_43
    Snippet: The risk of bias of each trial will be judged by two independent review authors as "Low", "Unclear", or "High" based on the critical domains, including random sequence generation, allocation concealment, blinding, incomplete outcome data, selective reporting and other source of biases. Disagreements will be resolved by discussion among all authors. If the disagreements cannot be resolved through discussion, an arbiter will make the final decision.....
    Document: The risk of bias of each trial will be judged by two independent review authors as "Low", "Unclear", or "High" based on the critical domains, including random sequence generation, allocation concealment, blinding, incomplete outcome data, selective reporting and other source of biases. Disagreements will be resolved by discussion among all authors. If the disagreements cannot be resolved through discussion, an arbiter will make the final decision.

    Search related documents:
    Co phrase search for related documents
    • allocation concealment and selective reporting: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • allocation concealment and sequence generation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • allocation concealment and trial bias: 1, 2, 3
    • allocation concealment and trial bias risk: 1
    • random sequence generation and selective reporting: 1, 2, 3, 4
    • random sequence generation and sequence generation: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • random sequence generation and trial bias: 1
    • random sequence generation and trial bias risk: 1
    • selective reporting and sequence generation: 1, 2, 3, 4, 5, 6, 7, 8
    • selective reporting and trial bias: 1, 2, 3, 4
    • selective reporting and trial bias risk: 1, 2, 3
    • sequence generation and trial bias risk: 1